Bermuda-based consolidation vehicle is the third incarnation of Sir Clive Cowdery’s acquisitive Resolution
Resolution Life, an insurance consolidation vehicle founded by Sir Clive Cowdery, has completed a $3bn fundraising and added several of the investors who contributed, including JPMorgan and KKR, to its board.
Bermuda-based Resolution Life, founded in 2017, is Cowdery’s latest vehicle for buying and merging insurers.
A previous UK company, also called Resolution, acquired a series of businesses in the 2000s before merging with Britannic Group and then being sold to Hugh Osmond’s Pearl Group, later becoming Phoenix Group.
Cowdery relaunched the Resolution business a second time, buying Friends Life in 2009 and adding other businesses from Axa Sun Life and Bupa. This was then sold to Aviva in 2014.
This latest, third incarnation has acquired $5.7bn of life insurance policies from US insurer Symetra, and in October 2018, agreed to buy various insurance businesses from AMP in Australia and New Zealand for A$3bn.
In a statement on November 18, Resolution Life said it has raised $3bn from investors to finance further deals.
Representatives from JPMorgan, KKR, the Nippon Life Insurance Company, Singaporean sovereign wealth fund Temasek, and USS, the UK’s largest pension fund, will join its board — alongside an unnamed Middle Eastern sovereign fund.
Credit Suisse Asset Management acted as a placement agent on the fundraising.
Cowdery, who is executive chair of the company, said: “Resolution Life will continue to grow and release trapped capital and stranded costs for life insurers across a number of markets. I am delighted to welcome our cornerstone investors onto our board.”
Source: Financial News
Can’t stop reading? Read more
State Street steps up push into secondaries as retail access expands
State Street steps up push into secondaries as retail access expands State Street is seeking to deepen its exposure to private markets secondaries as it looks to broaden access for retail investors, according to Yie-Hsin Hung, chief executive of State Street...
Hellman & Friedman tests $9bn-plus exit for medical device group Cordis
Hellman & Friedman tests $9bn-plus exit for medical device group Cordis Hellman & Friedman is weighing a potential sale of medical device company Cordis at a valuation of more than $9bn, in a move that could rank among the largest healthcare exits by a private...
Brookfield-backed Clean Max plans smaller $350m–$400m India IPO
Brookfield-backed Clean Max plans smaller $350m–$400m India IPO Brookfield-backed Clean Max Enviro Energy Solutions is preparing to revive its Indian IPO plans with a reduced offering of about $350m to $400m, as valuation pressures weigh on renewable energy listings....